The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism superarray

Basic and Clinical Pharmacology and Toxicology

Volumn 99, Issue 2, 2006, Pages 141-145

  Zhang, Chun Yu ^a   Feng, Yuan Xi ^a   Yu, Yang ^a   Sun, Wen Jing ^a   Bai, Jing ^a   Chen, Feng ^a   Fu, Song Bin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN; COLCHICINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 5; PROTEIN; PROTEIN DHFR; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATM GENE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; CYTOGENETICS; DHFR GENE; DRUG METABOLISM; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; MOUSE; MRP5 GENE; NONHUMAN; P53 GENE; PRIORITY JOURNAL;

ANIMALS; AUTOANTIGENS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CYTOGENETIC ANALYSIS; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; METHOTREXATE; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; TETRAHYDROFOLATE DEHYDROGENASE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33747070768     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_470.x     Document Type: Article

References (18)

1. Barbara, H., XX, Nevaldine, R. Rizwana & P. J. Hahn: Differential sensitivity of double minute chromosome to hydroxyurea treatment in cultured methotrexate-resistant mouse cells. Mut. Res. Genom. 1999, 406, 55-62.
2. Calatozzolo, C., M. Gelati, E. Ciusani, F. L. Sciacca, B. Pollo, L. Cajola, C. Marras, A. Silvani, L. V. Zuccarello, D. Croci, A. Boiardi & A. Salmaggi: Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J. Neurooncol. 2005, 74, 113-21.
3. Choudhury, A., A. Cuddihy & R. G. Bristow: Radiation and new molecular agents Part I: Targeting ATM-ATR checkpoints, DNA repair, and the proteasome. Semin. Radiat. Oncol. 2006, 16, 51-58.
4. Debabrata, B., P. M. Kuckuk, G. Capiaux, T. B. Alpdogan, R. Gorlick & J. R. Bertino: Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidilate synthase. Biochim. Biophys. Acta 2002, 1587, 164-173.
5. Hahn, P. J., B. Nevaldine & J. A. Longo: Molecular structure and evolution of double-minute chromosomes in methotrexate-resistant cultured mouse cells. Mol. Cell. Biol. 1992, 2, 2911-2918.
6. Hamkalo, B. A., P. J. Farnham, R. Johnston & R. T. Schimke: Ultrastructural features of minute chromosomes in a methotrexate-resistant mouse 3T3 cell line. Proc. Natl. Acad. Sci. U S A. 1985, 82, 1026-1030.
7. Hooijberg, J. H., H. J. Broxterman, M. Kool, Y. G. Assaraf, G. J. Peters, P. Noordhuis, R. J. Scheper, P. Borst, H. M. Pinedo & G. Jansen: Antifolate resistance mediated by the multidrug resistance protein MRP1 and MRP2. Cancer Res. 1999, 59, 2532-2535.
8. Lee, K., A. J. Klein-Szanto & G. D. Kruh: Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J. Natl. Cancer Inst. 2000, 92, 1934-1940.
9. Pandit, B., M. Roy, J. Dutta, B. K. Padhi & N. P. Bhattacharyya: Co-amplification of dhfr and a homologue of hmsh3 in a Chinese hamster methotrexate-resistant cell line correlates with resistance to a range of chemotherapeutic drugs. Cancer Chemotherap. Pharmacol. 2001, 48, 312-318.
10. Pommier, Y., O. Sordet, V. A. Rao, H. Zhang & K. W. Kohn: Targeting chk2 kinase: molecular interaction maps and therapeutic rationale. Curr. Pharm. Des. 2005, 11, 2855-2872.
11. Pratt, S., V. Chen,W. I. Perry, J. J. Starling & A. H. Dantzig: Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport. Eur. J. Pharm. Sci. 2005, 3, 110-116.
12. Richard, C., J. R. Horns, J. D. William & T. S. Robert: Gene Amplification in a Leukemic Treated with Methotrexate. J. Clin. Oncol. 1984, 2, 2-7.
13. Richard, G., G. Erdem, T. Tanya, W. Mark, B. Debabrata & R. B. Joseph: Intrinsic and Acquired Resistance to Methotrexate in Acute Leukemia. New Engl. J. Med. 1996, 335, 1041-1048.
14. Ritter, C. A., G. Jedlitschky, S. H. Meyer, M. Grube, K. Kock & H. K. Kroemer: Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab. Rev. 2005, 37, 253-278.
15. Ruiz, J. C., K. Choi, D. V. Hoff, I. B. Roninson & G. M. Wahl: Autonomously replicating episomes contain mdr1 genes in a multidrug-resistant human cell line. Mol. Cell. Biol. 1989, 9, 109-115.
16. Suzuki, T., K. Nishio & S. Tanabe: The MRP family and anticancer drug metabolism. Curr. Drug Metab. 2001, 2, 367-377.
17. Von Hoff, D. D., T. Waddelow, B. Forseth, K. Davidson, J. Scott & G. Wahl: Hydroxyurea accelerates loss of extrachromosomeally amplified genes from tumor cells. Cancer Res. 1991, 51, 6273-6279.
18. Zeng, H., Z. S. Chen, M. G. Belinsky, A. R. Philip & D. K. Gary: Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: Effect of polyglutamylation on MTX transport. Cancer Res. 2001, 61, 7225-7232.